resTORbio's Series A Round

resTORbio raised a round of funding on January 01, 2017.

resTORbio is a clinical stage biopharmaceutical company focusing on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.…

Articles about resTORbio's Series A Round: